Merit Medical Systems Financials - Benzinga

Merit Medical Systems Inc

MMSINASDAQ

Trade with Public

Trade with Public

$86.24

-7.15-7.66%

마지막 업데이트: Oct 30, 4:00 PM

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Merit Medical Systems Financials

Merit Medical Systems (MMSI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results

Merit Medical beat Q3 estimates, raised FY2026 EPS guidance, narrowed sales outlook; analysts lifted price targets to $110 and $106.

Avi Kapoor

PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.631B-$1.643B to $1.635B-$1.642B vs $1.636B Est

Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.631 billion-$1.643 billion to $1.635 billion-$1.642

Benzinga Newsdesk

PRO
Merit Medical Systems Q3 Adj. EPS $1.12 Beats $1.03 Estimate, Sales $416.244M Beat $410.376M Estimate

Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.03 by 8.74 percent. This is a 21.74 percent increase over earnings of $0.92 per share

Benzinga Newsdesk

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.

Avi Kapoor

PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B-$1.634B to $1.631B-$1.643B vs $1.620B Est

Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631 billion-$1.643

Benzinga Newsdesk

PRO
Merit Medical Systems Q2 Adj. EPS $1.19 Beats $0.96 Estimate, Sales $418.843M Beat $405.268M Estimate

Benzinga Newsdesk